Catalyst Wire Dossier Catalyst Wire Dossier

Imiquimod cream 2.5%

imiquimod · Actavis Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imiquimod cream 2.5%, covering 2019-12-13 to 2019-12-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses [Phase 3]

See pricing